Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jul 25, 2022 1:08pm
161 Views
Post# 34848598

RE:RE:Surprise

RE:RE:SurpriseSay it isn't so.  SB, balain, PLItheone all giving up on this finally.  ROF

Black mamba had it right so many years ago.  This has been a 30 year scam making many execs wealthy.  Thomvest wanted all those losses to pennies on the dollar.  All IMHO.

BTW, how is that lawsuit going?  More legal fees but no results.


PLITheOne wrote:

Really the only surprise would be that the SP isn't sitting at an all time low. Thomvest's plan was to drive this into the ground, outcome close now! $3600. to $0.36 in three years. 

Can't wait to see what a judge thinks of their unethical behavior!!!

Delisting in a couple weeks from Nasdaq, then they disappear into the darkness.

 

inventors wrote: That would be negative news, but best to know safery tolerance....?

There still seems to be scetchy info on Ryplazmin...lmnl own 30%...?

Mfg plant....?

The Antagonists switches...pre-clinical new indications...?

GPR84....?

OXER1...?

Clean shelf of a listed company. 15M cap and credit...perhaps today will be the new Bottom...?

Pierre performed better...?

 

 



<< Previous
Bullboard Posts
Next >>